IPO

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.

Amid intense market volatility, firms are turning to AI-powered energy storage to protect profits. One company's $53M deal shows how it's done.

Fresh off a major clinical trial victory, Alumis Inc. heads to a key investor conference. What's next for its promising pipeline and soaring stock?

After a dramatic pivot and massive fundraising, Galecto will detail its new hematology pipeline at a key conference. Here’s what investors are watching.

Amid soaring uranium prices, Refined Energy begins its maiden drill program in Saskatchewan's prolific Athabasca Basin, a high-stakes bet on nuclear's future.

In a strategic reverse merger with Rallybio, T-cell therapy innovator Candid Therapeutics secures over $505M to advance its groundbreaking autoimmune pipeline.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

With major trials underway for its cancer and vision drugs, NovaBridge's upcoming investor presentation could be a pivotal moment for the biotech firm.

McFarlane Lake Mining's latest drill results reveal a massive 95.4-meter gold intersection, signaling a major expansion of its Juby gold project.

Following strong shareholder support, Azimut Exploration launches a massive drilling campaign targeting deep gold potential and expanding known resources in Quebec.

With a strong cash runway and pivotal trials underway, Sionna Therapeutics aims to revolutionize CF treatment with a novel class of NBD1 stabilizer drugs.

Aldebaran spin-out Centauri Minerals reveals a massive resource update for its Rio Grande project, paving the way for a 2026 IPO and new exploration.

Nova Minerals confirms a major gold-copper system at its Estelle Project, with high-grade samples boosting US critical mineral prospects and exciting investors.

With a new CTO and data from 6.6M patients, SBC Medical is building an AI-driven empire. But will this tech leap enhance care or displace workers?

Green Rain Energy sets a date for its special dividend, championing a unique 'no-debt' model. But can it deliver on its shareholder-first promises?

Hopes for a new Huntington's gene therapy face a major delay as the FDA rejects uniQure's current data and calls for a more rigorous, complex study.

Riding record gold prices, TRX Gold shatters production records and cleans its balance sheet, fast-tracking a major expansion at its Buckreef project.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

A Chinese firm's 'Global Pioneer' status in cellular essence sparks debate on the future of biotech in cosmetics, medicine, and global regulation.

Indian firm Genus Power surpasses 26M smart meter deployments, leveraging its dominant role in national grid reform to expand its footprint worldwide.